TY - JOUR
KW - database research
KW - glycaemic control
KW - insulin therapy
KW - Observational study
KW - real-world evidence
KW - Type 2 diabetes
AU - M. Davies
AU - A. Alibegovic
AU - P. Kelkar
AU - U. Braae
AU - A. Jensen
AD - Diabetes Research Centre, College of Life Sciences, University of Leicester, Leicester General Hospital, Leicester, UK.
NIHR Leicester Biomedical Research Centre, Leicester General Hospital, Leicester, UK.
Novo Nordisk, Søborg, Denmark.
AN - 37722973
BT - Diabetes Obes Metab
DO - 10.1111/dom.15278
DP - NLM
ET - 2023/09/19
LA - eng
N1 - 1463-1326
Davies, Melanie J
Orcid: 0000-0002-9987-9371
Alibegovic, Amra Ciric
Kelkar, Pranav
Braae, Uffe Christian
Jensen, Anders Boeck
n/a/Novo Nordisk A/S/
Letter
England
Diabetes Obes Metab. 2023 Sep 18. doi: 10.1111/dom.15278.
PY - 2023
SN - 1462-8902
T2 - Diabetes Obes Metab
TI - Glycaemic control and weight outcomes after adding or switching to biphasic insulin aspart 30/70 in people with type 2 diabetes mellitus previously treated with basal-bolus insulin in UK clinical practice
ER -